SCHEMBL7142745

SCHEMBL7142745

CC(C)(C)OC(=O)Nc1cc(OCC#N)c(C#Cc2ccccc2)cc1NC(=O)CC(=O)c1cccc(-n2ccnc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
MAPK1 P28482 1/20 0.37
KIT P10721 1/20 0.36
DDR1 Q08345 1/20 0.36
ABL1 P00519 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
PORCN Q9H237 1/20 0.33
KDM4D Q6B0I6 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
ROCK2 O75116 1/20 0.32
RORC P51449 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140018 0.90 KIT (0.37) LMNAMAPK1KITDDR1ABL1
SCHEMBL5868817 0.85 ABL1 (0.40) LMNAMAPK1KITDDR1ABL1
SCHEMBL7149260 0.85 RORC (0.37) RORC
SCHEMBL7147238 0.85 ABL1 (0.39) KITDDR1ABL1L3MBTL1KDM4D
SCHEMBL7143253 0.85 ABL1 (0.36) LMNAMAPK1KITDDR1ABL1
SCHEMBL7143688 0.84 KDM4D (0.34) KITDDR1ABL1L3MBTL1CYP3A4
SCHEMBL7141902 0.84 ABL1 (0.37) LMNAMAPK1ABL1L3MBTL1KDM4D
SCHEMBL7139792 0.81 KDM4D (0.36) KITDDR1ABL1L3MBTL1KDM4D
SCHEMBL7140122 0.80 KDM4D (0.33) LMNAMAPK1KITDDR1ABL1
SCHEMBL5869035 0.80 ABL1 (0.39) LMNAMAPK1KITDDR1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed